Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases
Over the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to reduce the overdiagnosis and overtreatment of men with low-grade prostate ...
Apr 22, 2022
0
19